College of Pharmacy
In this section
Podcast Archive
In this section
HelixTalk Episode #20 - SMART
Date posted: January 20, 2015, 6:00 am
In this episode, we summarize and discuss the clinical implications of the SMART trial (Salmeterol Multicenter Asthma Research Trial; Nelson et al, 2006).
HelixTalk Episode #19 - Immunizations
Date posted: December 16, 2014, 6:00 am
In this episode, we discuss two controversial topics in the world of immunizations with Dr. Angelo -- the "high-dose" influenza vaccine and the expanded use of PCV13 (Prevnar-13).
HelixTalk Episode #18 - HIV
Date posted: December 2, 2014, 6:00 am
In this episode, we review HIV therapy with Dr. Cottreau with a particular focus on Truvada, Atripla, Complera, Stribild, and Triumeq.
HelixTalk Episode #17 - Overactive bladder
Date posted: November 18, 2014, 6:00 am
In this episode, we discuss the management of overactive bladder, including: oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), trospium (Sanctura), solifenacin (VESIcare), darifenacin (Enablex), fesoterodine (Toviaz), mirabegron (Myrbetriq), and onabotulinumtoxinA (Botox).
HelixTalk Episode #16 - New diabetes medications
Date posted: November 4, 2014, 6:00 am
In this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum).
HelixTalk Episode #15 - Cancer Screenings
Date posted: October 21, 2014, 6:00 am
In this episode, we review a wide variety of cancer screening guidelines with a particular focus on the two most controversial screening areas: breast cancer screening with mammography and prostate cancer screening with PSA levels.
HelixTalk Episode #14 - Midyear Table Talk
Date posted: October 7, 2014, 6:00 am
In this episode, we have a roundtable discussion regarding ASHP Midyear and the process of pursuing a pharmacy residency program.
HelixTalk Episode #13 - Obesity Guidelines and Weight Loss Pharmacotherapy
Date posted: September 23, 2014, 6:00 am
In this episode, we discuss the new 2013 ACC/AHA obesity guidelines with a particular focus on three medications for obesity: lorcaserin (Belviq), phentermine/topiramate (Qsymia), and orlistat (Xenical, Alli).
HelixTalk Episode #12 - Osteoporosis Guidelines and Two Newer Agents
Date posted: September 9, 2014, 6:00 am
In this episode, we review the National Osteoporosis Foundation's osteoporosis guidelines with a particular focus on two newer agents, denosumab (Prolia) and teriparatide (Forteo).
HelixTalk Episode #11 - Bordetella pertussis
Date posted: August 26, 2014, 6:00 am
In this episode, we discuss Bordetella pertussis (whooping cough) with Dr. Michael Fennewald.